Immunomodulatory Effect of Vitamin D in Allogenic Post-transplant

NCT02600988 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic Stem Cell Transplantation

Interventions

DRUG: 1000IU/day of Vitamine D
DRUG: 5000IU/day of Vitamine D

Sponsor

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla